CUMBERLAND PHARMACEUTICALS INCCPIXEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company that develops, manufactures and commercializes branded prescription medicines. Its core product portfolio covers acute care, gastroenterology, pain management and rare disease treatment, with its primary operating market being the United States, serving healthcare providers and patients in relevant care segments.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| A.J. Kazimi | 40.14% | 5.7M | — | 2024-02-09 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-18 | Caroline Young | Director | Grant | 1.8K | $2.80 | $5.0K |
| 2026-03-18 | Brown Martin S JR | Director | Grant | 1.8K | $2.80 | $5.0K |
| 2026-03-18 | James Jones | Director | Grant | 1.8K | $2.80 | $5.0K |
| 2026-03-18 | Kenneth Krogulski | Director | Grant | 1.8K | $2.80 | $5.0K |
| 2026-03-18 | Kenneth Krogulski | Director | Grant | 4.0K | $2.80 | $11.2K |
| 2026-03-18 | Galante Joseph C | Director | Grant | 1.8K | $2.80 | $5.0K |
1–6 of 6